Clinicopathological and prognostic factors for long-term survival in Chinese patients with metastatic renal cell carcinoma treated with sorafenib: a single-center retrospective study
Data on long-term survival and prognostic significance of demographic factors and adverse events (AEs) associated with sorafenib, an orally administered multikinase inhibitor in Chinese population with advanced renal cell carcinoma (RCC) are limited. Outcome data from adult patients (n = 256) with a...
Main Authors: | Zhang, Hai-Liang, Qin, Xiao-Jian, Wang, Hong-Kai, Gu, Wei-Jie, Ma, Chun-Guang, Shi, Guo-Hai, Zhou, Liang-Ping, Ye, Ding-Wei |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742216/ |
Similar Items
-
Critical appraisal of sorafenib in the treatment of Chinese patients with renal cell carcinoma
by: Ye, Ding-Wei, et al.
Published: (2014) -
Retrospective Analysis of the Efficacy and Safety of Sorafenib in Chinese Patients With Metastatic Renal Cell Carcinoma and Prognostic Factors Related to Overall Survival
by: Yu, Xiaoteng, et al.
Published: (2015) -
AB186. The efficacy and safety of sorafenib in Chinese patients with metastatic renal cell carcinoma and prognostic factors related to its efficacy
by: Yu, Xiaoteng, et al.
Published: (2015) -
Stabilization of metastatic myxopapillary ependymoma with sorafenib
by: Fegerl, Gundula, et al.
Published: (2012) -
Stabilization of metastatic myxopapillary ependymoma with sorafenib
by: Christine Marosi, et al.
Published: (2012-06-01)